baber/WOPTO huggingface dataset:
Patent MX-162590-A (MX)
Inventor: BRONICKI LUCIEN Y
IPC: F02C1/02
Filed: 1982-07-22
Abstract: The pressure of fluid supplied by a high-pressure line is reduced to a lower pressure suitable for a low-pressure utilization device located in an environment having an electrical grid by interposing a fluid motor between the high-pressure line and the low-pressure utilization device such that operation of the latter causes the high-pressure fluid to operate the motor and to exhaust into the utilization device. The fluid motor drives an asynchronous generator whose output is connected to the electrical grid through a switch whose state is normally open. The switch is maintained in a closed state only during operation of the motor by providing, for example, a pressure sensor in the exhaust of the motor for sensing the passage of fluid through the motor. As long as the utilization device is furnished with low-pressure fluid, the switch is closed and the output of the generator is fed directly into the power grid of the local environment, thereby reducing the amount of power being supplied to the local environment by the power company.
Patent MX-152047-A (MX)
Inventor: WIILEM MICHEL
IPC: H01B17/22
Filed: 1982-08-04
Abstract: The binding is disposed substantially symmetrically about a plane of symmetry which passes through the insulator and which is orthogonal to said conductor (10). It comprises a first ring (8) for occupying a portion of the circumferential groove, a second ring (9) for occupying the top groove, two conductor-retaining branches (5), and tightening means (2, 11) for tightening the binding. Each of said branches comprises a first end portion (7) in the form of a preformed spiral retainer for wrapping around said conductor, an intermediate portion for threading through said second ring when lodged in the top groove and through said first ring when lodged in the circumferential groove, and then extending in an arc of the same diameter as the circumferential groove to a second end portion which provides an eye (6) for engaging the tightening means.
Patent NZ-215655-A (NZ)
Title: Antiviral compositions containing azolylmethyloxiranes
Inventor: JANSSEN B
IPC: A61K31/41
Filed: 1986-04-02
Abstract: The application of compounds of the formula    <IMAGE>  (I)  where A, B and Z have the meanings stated in the description, for the treatment of viral infections is described.
Patent NZ-225354-A (NZ)
Title: Sport shoes: pneumatic resilient cylinder fitted to heel recess
Inventor: MACKNESS TERRY
IPC: A43B13/18
Filed: 1988-07-08
Abstract: An improved structure of the sole of shoes suitable for use in sports or any casual wear is characterized in that the mid-sole is provided with resilient spherical bodies within recesses in the front portion and/or the heel portion of the sole, and that the hardness of the resilient bodies can be adjusted to enhance the elasticity of the soles of the shoes by virtue of the fact that the spherical bodies can be inflated and deflated or can be bodily replaced, thereby enabling the requisite shock absorbing effect to relieve impact stress during running and fatigue during long walking to be obtained.
Patent NZ-228028-A (NZ)
Title: Ether, thioether, amino or n-containing heterocyclic substituted stilbene derivatives, intermediates, preparation processes and pharmaceutical compositions
Inventor: KLAUS MICHAEL
IPC: A61P37/08
Filed: 1989-02-17
Abstract: The novel compounds of the general formula 
<IMAGE>
 in which R<1> and R<2> independently of one another represent lower alkyl; or, taken together, represent alkylene having 3-5 C atoms in a straight chain; one of the radicals R<3> and R<4> denotes hydrogen and the other denotes hydrogen or lower alkyl; R<6> and R<7> denotes hydrogen or lower alkyl; R<5> and R<8> denote hydrogen, lower alkyl, lower alkoxy or halogen, X denotes -O-, -S-, -SO-, -SO2- or -NR<9>; R<9> denotes hydrogen, lower alkyl or acyl; Y denotes -S(O)mR<1><0> or -NHet, and, if X is - NR<9>-, -S-, -SO- or -SO2-, also denotes -N(R<1><1>)2 or -OR<1><2>; R<1><0> denotes lower alkyl; R<1><1> and R<1><2> denote hydrogen, lower alkyl or acyl; -NHet denotes a 5-8-membered, saturated or unsaturated monocyclic heterocycle bonded via an N atom; n denotes 2, 3 or 4 and m denotes 0, 1 or 2,
 can be used as active compounds for the treatment of diseases, for example neoplasias, dermatoses or presbyderma.
Patent NZ-234843-A (NZ)
Title: 2-oxo-1-oxa-3,8-diazaspiro(4,5)decane derivatives and pharmaceutical compositions
Inventor: TOTH EDIT
IPC: C07D211/22
Filed: 1990-08-09
Abstract: 4,4-disubstd piperidine derivs of formula (I) and their acid addn and quaternary ammonium salts are new. In (I) R1 = H or C0NHR; R = H, 1-12C alkyl, 3-6C cycloalkyl or a carboxyclic 6-10C aryl or carbocycline (6-10C aryl) 1-4C alkyl opt ring substd by one or more halo, 1-4C alkyl or 1-4C alkoxy; R2 = ethynyl or C0CH3; Ph1 and Ph2 = phenyl opt substd by one or more halo, 1-4C alkyl, 1-4C alkoxy, trihalo or 0H opt esterified by a 1-4C alkansic acid; n = 1-2. - 3 Cpds (I) ie 1-(3,3-bis(4-fluorophenyl)-2-propenyl)-4 ethynyl-4-hydroxypiperidine hydrochloride, (Ib) 1-(4,4-bis(4-fluorophenyl)-3- butenyl)-4-ethynyl-4-hydroxy piperidine hydrochloride (Ia) and 1-(4,4-bis(4-fluorophenyl)-3- butenyl)-4-benzylcarbamoyloxy-4 ethynylpiperidine are specifically claimed.
Patent NZ-239085-A (NZ)
Title: Cloning and expression of xylanase genes from fungal origin
Inventor: VAN DEN BROECK HENRIETTE CATHA
IPC: A23K30/18
Filed: 1991-07-23
Abstract: Methods and expression constructs are provided for the cloning of genes from fungal origin which encode polypeptides having xylanase activity and their overexpression in a selected microbial host cell. Xylanases of fungal origin generally have lower pH optima and remain stable over a broader pH range than do xylanases of bacterial origin. The present invention provides for the high level production of fungal xylanases which are may be used in a variety of industrial applications requiring xylanase activity at a low pH.
Patent NZ-263904-A (NZ)
Title: Unsaturated purinyl- and pyrimidinyl-phosphonate derivatives; pharmaceutical compositions
Inventor: CASARA PATRICK
IPC: C07F9/6561
Filed: 1994-02-25
Abstract: Novel unsaturated phosphonate derivatives of certain purines or pyrimidines useful as antiviral agents, to methods and intermediates useful for their preparation and to their end-use application as antiviral agents effective against DNA viruses, retroviruses and viruses involved in tumor formation.
Patent NZ-269124-A (NZ)
Title: Vaccine comprising helicobacter antigens and its use in treating such infections
Inventor: DOIDGE CHRISTOPHER VINCENT
IPC: A61P31/04
Filed: 1994-07-25
Abstract: The application discloses a method for the treatment of Heliobacter infection in a mammalian host, which comprises administration to said infected host of an immunologically effective amount of one or more Heliobacter antigen(s), optionally in association with a mucosal adjuvant.
Patent NZ-322134-A (NZ)
Title: Filling containers with particulate material
Inventor: GRIFFIN DAVID PETER
IPC: B65B11/50
Filed: 1996-11-14
Abstract: A multi-compartment container (12) is charged with a plurality of doses of powdered medicament so that the volume of each dose is less than that of the respective compartments in which it is contained. A respective protuberance is inserted into each respective compartment, which is then filled with medicament and the protuberance is then removed. The container may take the form of an apertured plate, in which case the filling step can be achieved by placing the container (12) on a porous bed (22) and in communication with a reservoir of particulate material, and then passing gas through the reservoir, the apertures in the container (12) and the bed (22). There is also disclosed apparatus for performing the method, the apparatus comprising a reservoir for the particulate material and conduit means (81) for relaying particulate material from the reservoir to the compartments, the conduit means including protuberances which are insertable into the compartments to reduce the available volume of the latter. The size of the doses can be controlled by appropriate selection of protuberance dimensions, and a plate-type container, when filled by the method, can be relatively easily sealed by, for example, the application of laminated foil.
Patent NZ-334423-A (NZ)
Title: 1:2 complex of germanium and 1,3-dicarboxylic acid
Inventor: VESELOVSKY VLADIMIR VSEVOLODOV
IPC: A61K33/24
Filed: 1997-09-05
Abstract: The complex is prepared by reacting an aromatic or non-aromatic, carbocyclic or heterocyclic 1,3-dicarboxylic acid, for example 2,6-pyridinedicarboxylic acid, with a tetraalkoxygermanium, such as tetramethoxygermanium or tetraethoxygermanium.  This reaction may be performed in an organic solvent, at a temperature within the range of 60 to 90 degrees celsius and under an inert gas atmosphere.  The target product, germanium bis(pyridine-2,6-dicarboxylate), is recovered by filtration and drying in vacuum. The germanium complex can be used in pharmaceutical compositions to treat infectious diseases and immuno- and interferon-deficient conditions in humans or animals.
Patent NZ-334759-A (NZ)
Title: Prevention of marine encrustation on bronze propellers comprising electroplating with Cu, spraying with 5% sodium hypochlorite and sodium chloride then sealing for 24 hours
Inventor: KEMPIN RONALD
IPC: C25D3/38
Filed: 1997-08-21
Abstract: Bronze propellers are prone to attack by marine organisms, such as barnacles, coral and algae, which attach themselves to the bronze metallic surface, creating lumps on the propeller, which adversely affect its balance and cause impedance and vibration of the propeller and its boat in the water. Anti-fouling paints are either too toxic for the marine environment or lack smoothness on the surface. These problems have been overcome by a combination of known steps, namely, polishing the propeller to prepare it for electroplating, cleansing to remove all traces of dirt and grease, electroplating with copper to a depth of at least 0.005" or 0.15 mm, followed by spraying with a standard solution (5 %) of sodium hypochlorite and sodium chloride in a suitable container to form a firmly adhering conversion coating of basic cupric chloride and then sealing for at least twenty-four hours. The preferred procedure for polishing is 60# grit size at 3500 sfm for roughing, followed by 180# grit size at 5500 sfm for finishing using grease as a polishing aid. Electroplating with copper to the minimum depth provides a smoothing effect ranging from 70 to 90 per cent. The container in which the hypochlorite spraying is carried out is preferably kept sealed until just before fitting and launching. A life expectancy of five (5) years can be anticipated with minimal maintenance every time the vessel is slipped.
Patent NZ-500250-A (NZ)
Title: Adrenergic beta-2 agonist eutomers, feed compositions and use for increasing muscle and decreasing fat
Inventor: ABERG A K GUNNAR
IPC: A23L29/00
Filed: 1998-04-29
Abstract: Disclosed is: a method of feeding livestock animals, enhancing feed efficiency in livestock animals, and enhancing muscle growth and decreasing body fat in livestock animals; comprising administering thereto an effective amount of the optically pure eutomer of the adrenergic beta-2 agonist salbutamol, while minimising or eliminating the side effects residing in the corresponding distomer; and a food composition comprising the admixture with protein-containing food materials of the optically pure eutomer of the adrenergic beta-2 agonist salbutamol.
Patent NZ-501455-A (NZ)
Title: Hydrazine derivatives characterised when Y signifies CO and R2 signifies methoxy such as (E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulphonyl)-4-methylvalerohydrazide
Inventor: BROADHURST MICHAEL JOHN
IPC: C07D333/34
Filed: 1998-06-18
Abstract: Hydrazine derivatives of formula (I) and their pharmaceutically acceptable salts inhibit not only the release of tumour necrosis factor alpha (TNF-a) and transforming growth factor alpha (TGF-a) from cells, but also keratinocyte proliferation. They are useful as medicaments, especially for the treatment of inflammation, fever, haemorrhage, sepsis, rheumatoid arthritis, osteoarthritis, multiple sclerosis or psoriasis. Wherein; Y signifies CO or SO2; R1 signifies (C1-C7) alkyl, (C2-C7) alkenyl, (C3-C7) cycloalkyl, (C3-C7) cycloalkyl-(C1-C7) alkyl, aryl or aryl-(C1-C7) alkyl; R2 signifies (C1-C7) alkyl, halo-(C1-C7) alkyl, aryl-(C1-C7) alkyl, aryl-(C2-C7) alkenyl or aryl when Y signifies SO2 and signifies (C1-C7) alkyl, halo-(C1-C7) alkyl, (C1-C7) alkoxy, (C1-C7) alkoxycarbonyl, acyl, (C3-C7) cycloalkyl, aryl, aryl-(C1-C7) alkyl, aryl-(C1-C7) alkoxy or NR5R6 when Y signifies CO; R3 signifies hydrogen, (C1-C7) alkyl optionally substituted by cyano, amino, hydroxy, (C1-C7) alkoxy, (C1-C7) alkoxycarbonly, heterocyclyl or heterocyclylcarbonyl, (C2-C7) alkenyl, (C2-C7) alkynyl, (C3-C7) cycloalkyl, (C3-C7) cycloalkyl- (C1-C7) alkyl, aryl-(C1-C7) alkyl, aryl-(C2-C7) alkenyl, aryl or heterocyclyl; or R2 and R3 together form the residue of a 5-, 6- or 7- membered cyclic amide, cyclic imide, cyclic sulphonamide or cyclic urethane group; R4 signifies (C1-C7) alkyl, hydroxy-(C2-C7) alkyl, (C3-C7) alkenyl, (C3-C7) cycloalkyl, (C3-C7) cycloalkly-(C1-C7) alkyl or a grouping of the formula X-aryl, X-heteroaryl or -(CH2)1-2-CH=CR7R8; X signifies a spacer group; R5 and R6 each individually signify hydrogen, (C1-C7) alkyl or aryl-(C1-C7) alkyl; and R7 and R8 together represent a (C2-C7) alkylene group in which one methylene group is optionally replaced by a hetero atom;
Patent NZ-506597-A (NZ)
Title: Treatment of female sexual dysfunction using apomorphine
Inventor: RONSEN BRUCE
IPC: A61K31/485
Filed: 1999-01-28
Abstract: The use in the manufacture of a medicament, an effective amount of apomorphine, wherein the effective amount is sufficient to increase intraclitoral blood flow and vaginal wall blood flow on sexual stimulation of a human female, but wherein the effective amount is less than the amount that induces substantial nausea in the female, for ameliorating sexual dysfunction in the human female.
Patent NZ-510689-A (NZ)
Title: Polymer conjugates of interferon beta-1a and uses
Inventor: WHITTY ADRIAN
IPC: A61K47/50
Filed: 1999-10-15
Abstract: A composition comprising a glycosylated interferon-beta-1a polypeptide coupled at an N-terminal end to a non-naturally occurring polymer containing a polyalkylene glycol moiety; and it's use to treat disease.
Patent NZ-511926-A (NZ)
Title: Pressurised metered dose inhalers (MDI) comprising an internal surface of either stainless steel or anodised aluminium
Inventor: GANDERTON DAVID
IPC: A61L9/04
Filed: 1999-11-23
Abstract: Disclosed are pressurised metered dose inhalers (MDIs) having part or all of their internal surfaces consisting of stainless steel or anodised aluminium, containing compositions to be delivered with said MDIs , such compositions consisting of an active ingredient, a hydrofluorocarbon propellant, a co-solvent and optionally a low volatility component. MDIs made of such material have reduced chemical degradation of the internal surface of the MDI due to the composition contained within, and are particularly useful for containing beta-2 antagonists, steroids and anti-cholinergic agents.
Patent NZ-512119-A (NZ)
Title: Separating and recovering components from plants
Inventor: HULST ANNE COENRAAD
IPC: D01B1/42
Filed: 1999-12-24
Abstract: The invention relates to the separation and recovery of components from genetically modified plants. The invention provides a method for separating components from a genetically modified plant, characterized in that the material is at the least partly fiberized and subsequently is separated into a fiber fraction and a juice stream, such that the fiber fraction principally comprises relatively firm tissues such as epidermis, sclerenchyma and vascular bundles, and the juice stream principally contains soft tissues such as parenchyma and cytosol.
Patent NZ-514712-A (NZ)
Title: Producing a cold-formable metal-coated strip having a residual (through thickness distribution) stress of no more than 100 Mpa
Inventor: CLANCY CATHERINE
IPC: C23C2/26
Filed: 2001-10-09
Abstract: A method of producing a metal coated steel strip comprises: a) forming a metal coating on a steel strip and b) conditioning the surface of the metal coated steel strip by smoothing the surface of the strip; the conditioning step producing residual stress of no more than 100 MPa in the strip.
Patent NZ-520183-A (NZ)
Title: An electrical circuit board and a multiconnector
Inventor: BOLOURI-SARANSAR MASUD
IPC: H01R13/6461
Filed: 2000-12-29
Abstract: An electrical circuit board and a multiconnector having protruding contact pins, which together form contact areas for providing contact with a complementary connector, are arranged such that the contact pins (6-13) extend out from one of the sides of the circuit board (1) substantially in a direction K which corresponds to the direction of coupling of a multiconnector and a complementary connector.
Patent NZ-521440-A (NZ)
Title: Medicament for combating respiratory depression
Inventor: CHRISTOPH THOMAS
IPC: A61K31/4468
Filed: 2001-05-05
Abstract: Disclosed is the use of compounds of formula 1 for the manufacture of medicaments for the treatment of respiratory depression, wherein the radical R is selected from the group of a) to f).
Patent NZ-521602-A (NZ)
Title: Accessing private wireless internet packet data communication system using PDCC,PDTC and PDMA
Inventor: LEE SUNG-HOON
IPC: H04W84/16
Filed: 2002-09-25
Abstract: An apparatus and method for accessing a private wireless Internet packet data communication system. A private packet data service apparatus includes a plurality of office BTSs positioned in an office packet data service zone and an office BSC for providing a wireless packet data service using a CDMA method. The office BTSs wirelessly communicate with terminals contained in a corresponding service zone. In the case where dialing numbers of calls requested by the office BTSs are not office packet service request signals, the office BSC transmits the calls to a public network BSC. In the case where dialing numbers of calls requested by the office BTSs are office packet service request signals, the office BSC provides the calls with a packet data service for which a non-authentication, a non-accounting, and an IP service are available. The office BSC includes a PDCC (Packet Data Call Controller), a PDTC (Packet Data Traffic Controller), and a PDMA (Packet Data Maintenance & Administration part). The PDCC generates or terminates an RP (Radio Packet) connection needed to perform packet data transmission/reception of a terminal between an AMC and a DCN (Data Core Network), and processes a state conversion concerning a packet call. The PDTC performs data transmission/reception between the AMC and the DCN. The PDMA performs an interface between a BAN and maintenance/administration blocks, checks states of the AMC and an ATM PVC, and checks a link state between the AMC and a DCN.
Patent NZ-534184-A (NZ)
Title: Document display system and method
Inventor: WILSON ERIC
IPC: G06F17/24
Filed: 2002-12-19
Abstract: A document presentation system is disclosed. The document presentation system includes a rendering unit that analyses user or publisher preferences to determine content layout and navigation by examining the dimensions of the available viewing area to determine a suitable document layout and navigation system, a formatting unit that resizes and rearranges content according to the content layout and navigation determined by the rendering unit, a display unit that presents content to a user and responds to user interaction, and a cache unit that stores reformatted content for display by the display unit.
Patent NZ-538191-A (NZ)
Title: New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
Inventor: SOUVIE JEAN-CLAUDE
IPC: A61P25/16
Filed: 2005-02-11
Abstract: A process for the industrial synthesis of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide of formula (I) is disclosed, wherein the process comprises an initial step of reacting 7-methoxy-1-tetralone of formula (III) with cyanoacetic acid to yield (7-methoxy-3,4-dihydro-1-naphthalenyl)acetonitrile (VI) and subsequently involving further reaction steps of reacting the compound of formula (VI) with a hydrogenation catalyst in the presence of an allyl compound and subjecting the resultant compound to reduction with hydrogen in the presence of Raney nickel in ammoniacal ethanol medium, then subjecting the product successively to the action of hydrochloric acid, sodium acetate and then acetic anhydride to obtain the agomelatine of formula (I).
Patent NZ-539956-A (NZ)
Title: Multilayer rotational moulding
Inventor: MAZIERS ERIC
IPC: B32B27/32
Filed: 2003-11-20
Abstract: Disclosed herein is a multilayer hollow packaging prepared by rotational moulding that comprises: (a) a first layer prepared from a composition comprising from 50 to 100 wt% of a polyethylene (PE) or of a polypropylene (PP) or of a mixture thereof, each being prepared with a Ziegler-Natta or with a metallocene-based catalyst system, and from 50 to 0 wt% of a functionalised polyolefin; (b) a second layer on either side of the first layer prepared from a material that is dissimilar from that of the first layer; (c) optionally a third layer, adjacent to the first layer prepared from a material that is dissimilar from that of the first layer and that is similar to or dissimilar from that of the second layer, wherein the adhesion between the first layer and the one or two other layers is achieved by the first layer composition. A method for preparing these rotomoulded multilayer hollow packaging articles is also disclosed.
Patent NZ-541332-A (NZ)
Title: Preventive or remedy for intrauterine growth retardation or gestational toxicosis
Inventor: KOBAYASHI MAMORU
IPC: A61K31/165
Filed: 2004-01-19
Abstract: Disclosed is the use of a phenylethanolaminotetralin derivative represented by the general formula (I) or a pharmaceutically acceptable salt thereof, as an active ingredient in the manufacture of a medicament for the prevention or treatment of intrauterine growth retardation or gestational toxicosis.
Patent NZ-544181-A (NZ)
Title: Sustained release of oxycodone multiparticulates
Inventor: WALDEN MALCOLM
IPC: A61K31/385
Filed: 2004-06-23
Abstract: Disclosed are melt extruded controlled release multiparticulates which contain oxycodone, water-insoluble ammonium methacrylate copolymer, plasticizer, lubricant and water permeability modifier, wherein said water permeability modifier is a water permeable ammonium methacrylate copolymer or hydroxypropyl methylcellulose.
Patent NZ-551288-A (NZ)
Title: Carboxamido opioid compounds that are derivatives of tramadol
Inventor: CARSON JOHN R
IPC: C07C237/00
Filed: 2005-05-11
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. The compounds are derivatives of tramadol wherein the methoxy substituent has been replaced with a carboxamido group. The compounds are useful in the treatment of pain.